Trial
NCT05967052
Investigation of Treating Chronic Fatigue Syndrome After COVID With Pharmacotherapy (Pregabalin) or Complex Rehabilitation
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland
Collaborators
Medical Research Agency, Poland
Condition
Chronic Fatigue Syndrome
Intervention
Pregabalin
Why stopped
occurrence of scientific risk
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-17